Y200-6694 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-3-chlorobenzamide

Y200-6694 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-3-chlorobenzamide
Y200-6694 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-3-chlorobenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-6694
N-(1H-1,3-benzodiazol-2-yl)-3-chlorobenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-6694

Molecular Formula

C14H10ClN3O (C14 H10 ClN3 O)

Compound Name

N-(1H-1,3-benzodiazol-2-yl)-3-chlorobenzamide

IUPAC name

N-(1H-13-benzodiazol-2-yl)-3-chlorobenzamide

SMILES

O=C(c1cccc(Cl)c1)Nc1nc(cccc2)c2[nH]1

InChI

InChI=1S/C14H10ClN3O/c15-10-5-3-4-9(8-10)13(19)18-14-16-11-6-1-2-7-12(11)17-14/h1-8H,(H2,16,17,18,19)

InChI Key

NNOLHIYETJFEDS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03387311

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

271.71

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.014

Distribution Coefficient, logD

3.005

Water Solubility, LogSw

-3.67

Polar Surface Area

43.755

Acid Dissociation Constant (pKa)

9.10

Base Dissociation Constant (pKb)

3.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

Y200-6694 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Aging Library (44940 compounds)

Antiviral Annotated Library (21441 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

Human Receptors Annotated Library (5376 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

SmartTM Library (51161 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • Proteases
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with Y200-6694 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-6694?
Check Price and Availability of Y200-6694, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-6694 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-6694
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-6694
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-6694 available by request